MD FRCS (Urol)
Sami is a consultant urologist at Addenbrookes’ Hospital in Cambridge and at Hinchingbrooke’ Hospital in Huntington. He has admitting rights to the Spire Cambridge Lea, Cambridge Nuffield and Melberry Huntington hospitals. He has special expertise in treating kidney stones (laser, keyhole surgery and shockwave lithotripsy), diagnosing and endoscopically managing ureteric and kidney urethelial cancer, managing male and female lower urinary tract disorders (due to enlarged prostate or bladder dysfunction), recurrent urinary tract infections, pelvic pain and chronic prostatitis. He was trained in robotic surgery for kidney and prostate cancer. He has a special interest in sexual dysfunction in addition to his skills in managing all aspects of general benign and cancer urology conditions. Sami had formal training as an expert witness.
Sami has joined St Georges’ Hospital Medical School and received his primary medical qualification from London University. He completed his basic surgical training in Yorkshire. Having a curious mind and an academic interest, he undertook over two-year research fellowship at the Bristol Urological Institute with world experts in the field of lower urinary dysfunction, incontinence and urodynamics. His research led to several publications and was awarded the Doctor of Medicine (MD) degree from London University. Sami has gained broad experience in General Urology by joining the Southwest of England Specialist Registrar higher surgical training program in Urology, which is one of the most competitive in the country.
Sami was then appointed as a clinical instructor in Urology in the United State of America (USA). During a busy year at the University of Pittsburgh Medical Centre, Cleveland Clinic and the Arthur Smith Institute of Urology in New York. he developed special expertise in all aspects of Endourology treating all types of urinary stones (with laser, keyhole surgery and shockwave lithotripsy) and endoscopic treatment of upper tract urothelial cancer. He was also trained in advanced minimally invasive urology techniques including laparoscopic and robotic surgery to treat kidney and prostate cancer.
Being organised and a team player led Sami to take on several management and leadership roles: he is currently the UK board member for the International Young Urologist Association (IYUA) and the local champion of the British Association of Urological Surgeons (BAUS) for Cambridge University. He has also acted as the UK trainees’ representative on the board of the European Society of Residents in Urology (ESRU), the Senior Urology Registrars Group (SURG) representative on the Andrology executive committee for BAUS, a member of the International Continence Society Ethics Committee and a representative for the British Medical Association (BMA). He is an active member of the Royal College of Surgeons of England, the European Association of Urology (EAU) and the American Urological Association (AUA) in addition to the British Association of Urological Surgeons (BAUS).
Sami enjoys training future doctors and urologists and has special interest in education and research. He is currently the lead for Cambridge University medical students. He contributes, as a faculty, to training courses for national and international residents and established young urologists. He has been invited as an expert speaker to local, national and international meetings. His hard work was recognized with numerous prizes and awards. As an acknowledgement of his achievements, he was included in the 5th and 6th editions of “Marquis Who’s Who in Medicine and Healthcare” and was nominated for “The Man of the Year in Medicine and Healthcare” in 2010.
Sami has contributed to literature with a number of book chapters and published several articles relating to kidney stones, bladder and prostate cancer in addition to bladder and prostate urinary symptoms. He acts as a reviewer for several high impact medical journals.
In his practice, Sami recognizes the threefold professional duty to treat, learn and teach focusing on safe patients’ journey and ensuring that high quality healthcare remains his main priority at all times. He believes that treatment should be individualized and tailored to patient’s preference in the context of up to date scientific evidence. Some publications listed below:
Al-Hayek S and Averch T.: The Role of Pre-Stenting for Ureteroscopy. In: Monga M, editor. Ureteroscopy: Indications, Instrumentation and Technique. 1st ed. Springer. In Press
Al-Hayek S. Urinary Tract Infection. In: Probert J, editor. An Atlas of Investigation and Diagnosis Urology. 1st ed. Oxford: Clinical Publishing; 2009. p. 9-23
Al-Hayek S, Abrams P. Clinical Diagnosis of Overactive Bladder. In: Raz S, Rodriguez LV, editors. Female Urology. 3rd ed. Philadelphia: Saunders Elsevier; 2008. p. 197-203
Al-Hayek S, Abrams P. The Standardization of Terminology of Lower Urinary Tract Function Recommended by the ICS. In: Cardozo L, Staskin D, editors. Textbook of Female Urology & Urogynegology. 2nd ed. Oxfordshire: Informa Healthcare; 2006. p. 759-70
Al-Hayek S, Jackman SV and Averch TD. The impact of obesity on urine composition and nephrolithiasis management. J Endourol. 2013 Mar;27(3):379-83
Yan X, Al-Hayek S, Gan W, Zhu W, Li X, Guo H. Minimally invasive percutaneous nephrolithotomy in preschool age children with kidney calculi (including stones induced by melamine-contaminated milk powder). Pediatr Surg Int. 2012 Oct;28(10):1021-4
Yan X, Zhu Z, Zhu W, Huang H, Al-Hayek S, Guo H. Photodynamic Effect of 5-aminolevulinic Acid (5-ALA)-loaded Nanoparticles on Bladder Cancer Cells: a Preliminary Investigation. Scand J Urol. 2013 Apr;47(2):145-51
Al-Hayek S and Abrams P. The fifty-year history of the ice water test in urology. J Urol. 2010 May; 183(5): 1686-92
Abdul-Rahman A, Al-Hayek S and Belal M. Urodynamic studies in the evaluation of the older man with lower urinary tract symptoms: when, which ones, and what to do with the results. Therapeutic Advances in Urology 2010; 2 (5-6): 187-194
Al-Hayek S and Abrams P. Cystometry and overactive bladder: The need for provocative testing. Current Bladder Dysfunction Reports 2009; 4(4): 181-239
Al-Hayek S, Belal M, Abrams P. Does the patient’s position influence the detection of detrusor overactivity? Neurourol Urodyn 2008; 27(4): 279-86
Boddy JL, Pike DJ, Al-Hayek S, Shaida N, Malone PR. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer. Prostate Cancer Prostatic Dis 2005; 8(4): 349-52
Al-Hayek S and Abrams P. Incontinence in the elderly. Women’s Health Medicine 2005; 2(6): 46-50
Al-Hayek S and Abrams P. Stress incontinence, why it occurs? Women’s Health Medicine 2005; 2(6): 26-8
Al-Hayek S, Thomas A, Abrams P. Natural history of detrusor contractility–minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor underactivity. Scand J Urol Nephrol Suppl 2004; (215): 101-8
Al-Hayek S and Abrams P. Women’s lower urinary tract function and dysfunction: definitions and epidemiology. Minerva Ginecol 2004 Aug; 56(4): 311-25